Health Canada is inviting feedback on two draft guidelines that explain the scientific information that device manufacturers should provide in support of their pre-market licence and amendment applications for Class III and IV in vitro diagnostics.
While one guideline explains the submission of this information in the global STED format (ie the Summary Technical Document),...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?